pharmaceutical company

NATCO Pharma Q3 profit plunges around 38%, stock hits 52-week low

NATCO Pharma Ltd reported a 37.75 per cent decline in consolidated net profit to ₹132.4 crore for Q3 FY2025, down…

11 hours ago